Filing Details

Accession Number:
0001213900-23-088896
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-20 20:14:16
Reporting Period:
2023-11-16
Accepted Time:
2023-11-20 20:14:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1788028 Jasper Therapeutics Inc. JSPR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208907 G Thomas Wiggans C/O Jasper Therapeutics, Inc.
2200 Bridge Pkwy, Suite 102
Redwood City CA 94065
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Stock Acquisiton 2023-11-16 10,000 $0.60 10,000 No 4 P Direct
Voting Common Stock Acquisiton 2023-11-17 10,000 $0.60 20,000 No 4 P Direct
Voting Common Stock Acquisiton 2023-11-20 10,000 $0.63 30,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5889 to $0.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.616 to $0.64, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.